IL162172A0 - Methods for the purification of levofloxacin - Google Patents

Methods for the purification of levofloxacin

Info

Publication number
IL162172A0
IL162172A0 IL16217202A IL16217202A IL162172A0 IL 162172 A0 IL162172 A0 IL 162172A0 IL 16217202 A IL16217202 A IL 16217202A IL 16217202 A IL16217202 A IL 16217202A IL 162172 A0 IL162172 A0 IL 162172A0
Authority
IL
Israel
Prior art keywords
levofloxacin
purification
methods
Prior art date
Application number
IL16217202A
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/263,192 external-priority patent/US7629458B2/en
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL162172A0 publication Critical patent/IL162172A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
IL16217202A 2001-11-29 2002-11-27 Methods for the purification of levofloxacin IL162172A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US33431601P 2001-11-29 2001-11-29
US35493902P 2002-02-11 2002-02-11
US26296502A 2002-10-03 2002-10-03
US10/263,192 US7629458B2 (en) 2001-10-03 2002-10-03 Preparation of levofloxacin and hemihydrate thereof
PCT/US2002/038182 WO2003045329A2 (en) 2001-11-29 2002-11-27 Methods for the purification of levofloxacin

Publications (1)

Publication Number Publication Date
IL162172A0 true IL162172A0 (en) 2005-11-20

Family

ID=31892240

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16217202A IL162172A0 (en) 2001-11-29 2002-11-27 Methods for the purification of levofloxacin

Country Status (13)

Country Link
EP (1) EP1460997A4 (en)
JP (3) JP2005527484A (en)
CN (1) CN1596256A (en)
AU (1) AU2002365416A1 (en)
CA (1) CA2466860A1 (en)
HR (1) HRP20040546A2 (en)
HU (1) HUP0500285A3 (en)
IL (1) IL162172A0 (en)
IS (1) IS7288A (en)
MX (1) MXPA04005196A (en)
NO (1) NO20042731L (en)
PL (1) PL374558A1 (en)
WO (1) WO2003045329A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161164A0 (en) 2001-10-03 2004-08-31 Teva Pharma Preparation of levofloxacin and forms thereof
US20060276463A1 (en) * 2002-12-16 2006-12-07 Sharma Tarun K Pure levofloxacin hemihydrate and processes for preparation thereof
KR100704641B1 (en) * 2004-07-21 2007-04-06 주식회사유한양행 Methods for the preparation of levofloxacin having a high purity
JP2006273718A (en) * 2005-03-28 2006-10-12 Shiono Chemical Co Ltd Method for producing levofloxacin-1/2 hydrate
CN1321121C (en) * 2005-04-21 2007-06-13 浙江医药股份有限公司新昌制药厂 Preparation and post-treatment method of levofloxacin
US7964723B2 (en) * 2008-08-02 2011-06-21 Apeloa-Kangyu And practical process for exclusively producing (S)-9-fluoro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido-[1,2,3,de][1,4]benzoxazine-6-carboxylic acid hemihydrate
CN102070650B (en) * 2011-01-28 2012-06-27 山东省药品检验所 Preparation method for levofloxacin-N-oxide
US20120251685A1 (en) * 2011-04-04 2012-10-04 Martek Biosciences Corporation Oil-in-Water Emulsions Comprising a Polyunsaturated Fatty Acid and Methods of Making the Same
CN105823851A (en) * 2015-12-15 2016-08-03 浙江海洋学院 Detection method for ofloxacin enantiomer in seawater
CN108218892A (en) * 2018-03-16 2018-06-29 乐山职业技术学院 A kind of purification process of lavo-ofloxacin
CN114507242B (en) * 2022-01-26 2023-05-19 上虞京新药业有限公司 Preparation method of levofloxacin with high optical purity

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK170473B1 (en) * 1985-06-20 1995-09-11 Daiichi Seiyaku Co S (-) - pyridobenzoxazinforbindelser
US5237060A (en) * 1985-12-10 1993-08-17 Bayer Aktiengesellschaft Process of preparing enantiomerically pure 1,8-bridged 4-quinolone-3-carboxylic acids
TW208013B (en) * 1990-03-01 1993-06-21 Daiichi Co Ltd
KR0131914B1 (en) * 1992-10-07 1998-04-17 조아퀸 가리데 센트멘나트 Process for obtaining benzoxanines useful for the synthesis of ofloxacin, levofloxacin and derivatives and derivatives thereof
KR0125115B1 (en) * 1994-03-22 1997-12-05 김은영 Process for preparing piperazinyl quinolone derivatives
KR100309871B1 (en) * 1999-02-24 2001-10-29 윤종용 Process for Preparing (-)Pyridobenzoxazine Carboxylic Acid Derivatives
IL161164A0 (en) * 2001-10-03 2004-08-31 Teva Pharma Preparation of levofloxacin and forms thereof

Also Published As

Publication number Publication date
HUP0500285A2 (en) 2005-06-28
CN1596256A (en) 2005-03-16
EP1460997A4 (en) 2005-06-15
WO2003045329A3 (en) 2004-02-19
HUP0500285A3 (en) 2009-03-30
IS7288A (en) 2004-06-21
WO2003045329A2 (en) 2003-06-05
NO20042731L (en) 2004-06-29
JP2006219496A (en) 2006-08-24
JP2005527484A (en) 2005-09-15
EP1460997A2 (en) 2004-09-29
CA2466860A1 (en) 2003-06-05
JP2008007517A (en) 2008-01-17
AU2002365416A1 (en) 2003-06-10
MXPA04005196A (en) 2005-11-23
PL374558A1 (en) 2005-10-31
HRP20040546A2 (en) 2004-10-31

Similar Documents

Publication Publication Date Title
HK1126953A1 (en) Fixtures for holding micro-organs
AU2002348135A1 (en) Methods for the treatment of addiction
HK1056864A1 (en) Syngas purification process
GB0128457D0 (en) Knowledge system
AU2002301971A1 (en) Syngas Purification Process
IL143106A (en) Process for the preparation of diphenylmethylthioacetamide
SI1697383T1 (en) Process for the purification of tacrolimus
HUP0500285A3 (en) Methods for the purification of levofloxacin
HUP0302530A3 (en) Process for the purification of 2-nitro-4-methylsulphonylbenzoic acid
GB0209222D0 (en) Purification process
GB0123145D0 (en) Apparatus for the purification of water
PL373627A1 (en) Process for the preparation of melamine
HUP0303025A3 (en) Process for the preparation of arylethanoldiamines
PT1698338E (en) S-methyl-dihydro-ziprasidone for the treatment of schizophrenia
PL371583A1 (en) Process for the preparation of 7alpha-methylsteroids
SG111997A1 (en) Improved process for the preparation of polyalkylphenoxyaminoalkanes
GB0113300D0 (en) Purification process
IL164788A0 (en) Process for the preparation of 3-isochromanone
AU2002366004A1 (en) Process for the purification of contaminated oils
GB0116022D0 (en) Purification process
PL368905A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
IL159508A0 (en) Apparatus for the purification of water
SI1395580T1 (en) Method for the purification of triazolylmethylepoxides
AU2003248597A1 (en) The purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
AU2002316900A1 (en) Method for the purification of triazolylmethylepoxides